2015
DOI: 10.2147/ijn.s72590
|View full text |Cite
|
Sign up to set email alerts
|

In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines

Abstract: One of the promising strategies for improvement of cancer treatment is based on magnetic drug delivery systems, thus avoiding side effects of standard chemotherapies. Superparamagnetic iron oxide (SPIO) nanoparticles have ideal properties to become a targeted magnetic drug delivery contrast probes, named theranostics. We worked with SPIO condensed colloidal nanocrystal clusters (MagAlg) prepared through a new soft biomineralization route in the presence of alginate as the polymeric shell and loaded with doxoru… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
29
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 76 publications
(41 citation statements)
references
References 29 publications
10
29
0
Order By: Relevance
“…Doxorubicin when introduced as nanoparticle composites to the cells, is shown to confer less toxicity to the normal cells. There are previous reports that Doxorubicin-loaded colloidal nanoassembles confer less cytotoxicity compared to direct treatment with Doxorubicin in NIH3T3 mouse fibroblast cells [30]. Corresponding to this, our results from MTT assay showed Doxorubicin-loaded iron oxide nanoparticles induced cytotoxicity to the MCF-7 and SKBR-3 breast cancer cells at specific concentrations.…”
Section: Drug Release From Carrier Nanoparticlesupporting
confidence: 86%
“…Doxorubicin when introduced as nanoparticle composites to the cells, is shown to confer less toxicity to the normal cells. There are previous reports that Doxorubicin-loaded colloidal nanoassembles confer less cytotoxicity compared to direct treatment with Doxorubicin in NIH3T3 mouse fibroblast cells [30]. Corresponding to this, our results from MTT assay showed Doxorubicin-loaded iron oxide nanoparticles induced cytotoxicity to the MCF-7 and SKBR-3 breast cancer cells at specific concentrations.…”
Section: Drug Release From Carrier Nanoparticlesupporting
confidence: 86%
“…Because the fibroblastic cell lines have been known to release exogenous MMPs, we expected that MMP release from NIH3T3 cell could accelerate the breakdown of the nanoclusters in addition to MMP-2 in cultivating medium. Although we confirmed the anti-cancer activity against mouse fibroblast cell lines, we speculate that the results employing human cancer cell line would be similar based on the previous studies employing NIH3T3 cells [44]. After the live/dead cell assay, the percentages of the dead cells with respect to total cells were 1.0±1.7%, 7.1±4.7%, 93.2±3.4%, and 1.1±1.5% for native AuNP, the nanoclusters without MMP-2, and those with MMP-2, and control, respectively.…”
Section: Cytotoxicity Of the Nanoclusterssupporting
confidence: 85%
“…As CAB could be considered as a kind of cationic surfactant, the mixed surfactant system formed from CAB and SDS in aqueous solution will be a novel photo-sensitive catanionic self-assembly system. Mouse fibroblast, NIH 3T3 cells have been widely used to evaluate the in vitro cytotoxic effect and cellular uptake of nanoparticles41424344. So NIH 3T3 cells were chosen to assess the cytotoxicity of the blank CAB/SDS system and cellular uptake of rhodamine B (RhB)-loaded system in our present study.…”
mentioning
confidence: 99%